These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 35456705)

  • 1. Effect of Solvents, Stabilizers and the Concentration of Stabilizers on the Physical Properties of Poly(d,l-lactide-
    Alkholief M; Kalam MA; Anwer MK; Alshamsan A
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brigatinib loaded poly(d,l-lactide-co-glycolide) nanoparticles for improved anti-tumoral activity against non-small cell lung cancer cell lines.
    Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Bhatia S; Al-Harrasi A
    Drug Dev Ind Pharm; 2021 Jul; 47(7):1112-1120. PubMed ID: 34551665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer.
    Sun SB; Liu P; Shao FM; Miao QL
    Int J Clin Exp Med; 2015; 8(10):19670-81. PubMed ID: 26770631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, evaluation, and
    Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
    Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.
    Perez C; Sanchez A; Putnam D; Ting D; Langer R; Alonso MJ
    J Control Release; 2001 Jul; 75(1-2):211-24. PubMed ID: 11451511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug.
    Sahana DK; Mittal G; Bhardwaj V; Kumar MN
    J Pharm Sci; 2008 Apr; 97(4):1530-42. PubMed ID: 17722098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
    Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Nisin-Loaded PLGA Nanoparticles Prepared with Rhamnolipid Cosurfactant against
    Üstün A; Örtücü S
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naringin as Sustained Delivery Nanoparticles Ameliorates the Anti-inflammatory Activity in a Freund's Complete Adjuvant-Induced Arthritis Model.
    Mohanty S; Konkimalla VB; Pal A; Sharma T; Si SC
    ACS Omega; 2021 Nov; 6(43):28630-28641. PubMed ID: 34746558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
    Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
    Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
    Li JL; Zheng CL; Liu JP; Zhu JB
    Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib and Piperine co-loaded PLGA nanoparticles: Development, characterization, and anti-cancer activity against hepatocellular carcinoma cell line.
    Alhudaithi SS; Abul Kalam M; Binobaid L; Ali R; Almutairi MM; Qamar W; Bin Hithlayn H; Almutairi A; Alshememry AK
    Saudi Pharm J; 2024 May; 32(5):102064. PubMed ID: 38633710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats.
    Sonaje K; Italia JL; Sharma G; Bhardwaj V; Tikoo K; Kumar MN
    Pharm Res; 2007 May; 24(5):899-908. PubMed ID: 17377747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.
    Sahoo SK; Panyam J; Prabha S; Labhasetwar V
    J Control Release; 2002 Jul; 82(1):105-14. PubMed ID: 12106981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies.
    Sanna V; Roggio AM; Posadino AM; Cossu A; Marceddu S; Mariani A; Alzari V; Uzzau S; Pintus G; Sechi M
    Nanoscale Res Lett; 2011 Mar; 6(1):260. PubMed ID: 21711774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol.
    Guan Q; Sun S; Li X; Lv S; Xu T; Sun J; Feng W; Zhang L; Li Y
    J Mater Sci Mater Med; 2016 Feb; 27(2):24. PubMed ID: 26704541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation.
    Godara S; Lather V; Kirthanashri SV; Awasthi R; Pandita D
    Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110576. PubMed ID: 32228957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles.
    Varshosaz J; Taymouri S; Hamishehkar H; Vatankhah R; Yaghubi S
    Res Pharm Sci; 2017 Jun; 12(3):222-232. PubMed ID: 28626480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and
    Jonderian A; Maalouf R
    Front Pharmacol; 2016; 7():458. PubMed ID: 27999542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.